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pTo the Editor: Ethnic disparities in contemporary ST-segment
elevation myocardial infarction (STEMI) management have not
been well characterized (1). The National Cardiovascular Data
Registry Acute Coronary Treatment and Intervention Outcome
Network–Get With The Guidelines Registry (ACTION Registry–
GWTG) is the largest national database including consecutive
acute coronary syndrome patients from all U.S. geographic regions
and therefore provides a unique opportunity to compare contem-
porary treatment patterns and outcomes between Hispanic and
non-Hispanic white STEMI patients.
Between January 2007 and March 2009, 46,245 STEMI
patients were treated at 333 sites and included in the ACTION
Registry–GWTG. Race/ethnicity was self-reported by the patient
or family member, and classified by U.S. Census Bureau categories.
A total of 5,633 patients who were neither Hispanic nor White, or
who had missing race/ethnicity information were excluded. Patient
characteristics, hospital treatment, in-hospital outcomes, and dis-
charge therapies were compared between Hispanic and non-
Hispanic white groups. Continuous variables were compared with the
Wilcoxon rank sum test, and categorical variables with the Mantel-
Haenszel chi-square test. Logistic generalized estimating equation
modeling examined associated risk-adjusted mortality, adjusting for
patient-level risk factors adapted from a validated mortality risk model
and hospital characteristics (number of beds, geographic location,
academic status, percutaneous coronary intervention [PCI] capability,
and percent Hispanic patients treated).
Hispanics represented 4.1% (n  1,655) of STEMI patients in
ACTION Registry–GWTG. Hispanics were younger (median age:
57 vs. 62 years, p  0.0001), more frequently had diabetes (33% vs.
21%, p  0.0001), and had lower prevalence of prior MI (15% vs.
19%, p  0.001) and prior revascularization procedures (18.6% vs.
23.4%, p  0.0001) compared with non-Hispanic whites. Hispanics
ere significantly more likely to be uninsured (27% vs. 12%, p 
.0001). Both ethnic groups sought care at similar types of hospitals.
Significant delays in initial triage and reperfusion were observed
or Hispanic patients (Table 1). Use of acute medications (aspirin
8%, clopidogrel 87%, beta-blockers 95%, anticoagulation 89%,
nd glycoprotein IIb/IIIa inhibitors 70%) and primary PCI was
imilar between groups.
Unadjusted in-hospital death (5% vs. 5.9%, p  0.14) was
imilar between ethnic groups, and persisted after adjustment for
atient and hospital characteristics (adjusted odds ratio: 1.07; 95%
onfidence interval: 0.81 to 1.43). The mean in-hospital length of
tay was longer among Hispanics (4.85  5.03 days vs. 4.38 
.54 days, p  0.0001). sPrescriptions of evidence-based discharge medications were
imilar between ethnic groups (aspirin 98%, clopidogrel 91%,
eta-blockers 96%, and statins 92%) although differences in
ischarge care were noted (Table 1).
Despite a growing population, Hispanics remained underrep-
esented in nationwide registries (1). Several reasons can be
ostulated. Enrollment in this voluntary registry may result in
nderrepresentation of regions and hospitals enriched with His-
anic patients. Less likely to be insured, Hispanics may also be less
ikely to have a regular source of medical care (1,2). Because of the
act that a larger proportion of Hispanics in the United States are
ounger, there is an expected lower prevalence of CAD.
Our study found significant differences in the process of care.
imes to presentation, first electrocardiogram, and reperfusion
herapy were longer in Hispanic patients. The reasons for these
elays cannot be elucidated from the information in the
egistry; however, several potential explanations could be of-
ered. Cultural differences, lack of recognition or knowledge of
he alarming symptoms, language-related barriers, insurance
tatus, social support, and educational level, may all play a role
n this delay (2– 4). DuBard et al. (3) demonstrated that the
anguage barrier is a major factor associated with poor recog-
ition of cardiovascular symptoms among Hispanic patients.
ambert et al. (4) demonstrated that arriving to the emergency
oom without the use of the ambulance system was associated
ith reperfusion delays and significant increases in 30-day mortality.
molderen et al. (2) showed longer pre-hospital delays to treatment and
ecreased utilization of reperfusion therapy among uninsured patients.
Despite differences in clinical characteristics and delays to reperfu-
ion, the adjusted in-hospital mortality was similar between ethnic
roups. This phenomenon, labeled the “Hispanic paradox,” has also
een noted in other conditions (1). In-hospital use of evidence-based
nd discharge therapies was remarkably similar between ethnic
roups, and provide reassuring evidence of improvements instituted in
he health system to eliminate racial/ethnic treatment disparities, a
rincipal goal of Healthy People 2010 (5). However, delays to
reatment and differences in post-discharge care remain evident
mong contemporary STEMI patients (1). The relationship between
ospital care, in-hospital outcomes, as well as its long-term follow-up
mplications is certainly an area that requires future research efforts.
In conclusion, Hispanic patients treated for STEMI have similar
linical outcomes compared with non-Hispanic-whites. However, longer
elays to STEMI recognition and reperfusion treatment, as well as less
tilization of evidence-based discharge care, were observed among His-
anic patients. Quality improvement initiatives and education efforts
pecifically designed for the Hispanic population are warranted.
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Initial Evaluation, Times to Intervention, In-Hospital TreTable 1 Initial Evaluation, Times to Intervention, I
H
(n
Initial evaluation and times to intervention
Symptom onset to hospital arrival, h 2.0
Ambulance use
Pre-hospital ECG
Arrival to ECG, min 8
Arrival to ECG 10 min
Door to balloon, min 74
Door to balloon 90 min
In-hospital treatment during first 24 h
Diagnostic catheterization
Reperfusion therapy
Primary PCI
Drug-eluting stent
Discharge care
Smoking cessation counseling
Diet counseling
Exercise counseling
Cardiac rehabilitation referral
Values are mean (range) or %.
ECG  electrocardiogram; PCI  percutaneous coronary interventiointracardiac ischemia detection device for continuous surveillance
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Letter to the EditorIntracardiac Electrogram
and Ischemia Alert
In an elegant study, Fischell et al. (1) employed an implantablefor ST-segmental shifts as a warning system. During a median
follow-up of 1.5 years, shifts exceeding 3 SDs were an accurate marker
for thrombotic coronary occlusion, allowing for a median alert-to-
door time of 20 min for patients at high risk of recurrent coronary
yndromes who typically present with 2- to 3-h delays. The feasibilityatmen-Hos
ispan
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(1.0–
41.5%
32.8%
(4–1
61.2%
(55–
69.4%
89.1%
91.5%
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47.9%
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95.2%
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68.9%f such a strategy was earlier established clinically with temporary
